Literature DB >> 8577769

Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.

P van der Geer1, S Wiley, G D Gish, V K Lai, R Stephens, M F White, D Kaplan, T Pawson.   

Abstract

The Shc adaptor protein contains two phosphotyrosine [Tyr(P)]binding modules--an N-terminal Tyr(P) binding (PTB) domain and a C-terminal Src homology 2 (SH2) domain. We have compared the ability of the Shc PTB domain to bind the receptors for nerve growth factor and insulin, both of which contain juxtamembrane Asn-Pro-Xaa-Tyr(P) motifs implicated in PTB binding. The Shc PTB domain binds with high affinity to a phosphopeptide corresponding to the nerve growth factor receptor Tyr-490 autophosphorylation site. Analysis of individual residues within this motif indicates that the Asn at position -3 [with respect to Tyr(P)], in addition to Tyr(P), is critical for PTB binding, while the Pro at position -2 plays a less significant role. A hydrophobic amino acid 5 residues N-terminal to the Tyr(P) is also essential for high-affinity binding. In contrast, the Shc PTB domain does not bind stably to the Asn-Pro-Xaa-Tyr(P) site at Tyr-960 in the activated insulin receptor, which has a polar residue (Ser) at position -5. Substitution of this Ser at position -5 with Ile markedly increased binding of the insulin receptor Tyr-960 phosphopeptide to the PTB domain. These results suggest that while the Shc PTB domain recognizes a core sequence of Asn-Pro-Xaa-Tyr(P), its binding affinity is modulated by more N-terminal residues in the ligand, which therefore contribute to the specificity of PTB-receptor interactions. An analysis of residues in the Shc PTB domain required for binding to Tyr(P) sites identified a specific and evolutionarily conserved Arg (Arg-175) that is uniquely important for ligand binding and is potentially involved in Tyr(P) recognition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8577769      PMCID: PMC40012          DOI: 10.1073/pnas.93.3.963

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides.

Authors:  G Waksman; D Kominos; S C Robertson; N Pant; D Baltimore; R B Birge; D Cowburn; H Hanafusa; B J Mayer; M Overduin; M D Resh; C B Rios; L Silverman; J Kuriyan
Journal:  Nature       Date:  1992-08-20       Impact factor: 49.962

2.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation.

Authors:  B L Hempstead; S J Rabin; L Kaplan; S Reid; L F Parada; D R Kaplan
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

4.  Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.

Authors:  L E Marengere; T Pawson
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

5.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity.

Authors:  M F White; J N Livingston; J M Backer; V Lauris; T J Dull; A Ullrich; C R Kahn
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

6.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

Authors:  G Pelicci; L Lanfrancone; F Grignani; J McGlade; F Cavallo; G Forni; I Nicoletti; F Grignani; T Pawson; P G Pelicci
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

7.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Authors:  C A Koch; D Anderson; M F Moran; C Ellis; T Pawson
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

8.  The NPXY internalization signal of the LDL receptor adopts a reverse-turn conformation.

Authors:  A Bansal; L M Gierasch
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

9.  Overexpression of Shc proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit.

Authors:  L Lanfrancone; G Pelicci; M F Brizzi; M G Aronica; C Casciari; S Giuli; L Pegoraro; T Pawson; P G Pelicci; M G Arouica
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

10.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.

Authors:  M Rozakis-Adcock; J McGlade; G Mbamalu; G Pelicci; R Daly; W Li; A Batzer; S Thomas; J Brugge; P G Pelicci; J Schlessinger; T Pawson
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

View more
  25 in total

1.  Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo.

Authors:  K S Ravichandran; M M Zhou; J C Pratt; J E Harlan; S F Walk; S W Fesik; S J Burakoff
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain.

Authors:  Z Zhang; C H Lee; V Mandiyan; J P Borg; B Margolis; J Schlessinger; J Kuriyan
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

3.  Efficient T-cell receptor signaling requires a high-affinity interaction between the Gads C-SH3 domain and the SLP-76 RxxK motif.

Authors:  Bruce T Seet; Donna M Berry; Jonathan S Maltzman; Jacob Shabason; Monica Raina; Gary A Koretzky; C Jane McGlade; Tony Pawson
Journal:  EMBO J       Date:  2007-01-18       Impact factor: 11.598

4.  High-affinity binding of the Drosophila Numb phosphotyrosine-binding domain to peptides containing a Gly-Pro-(p)Tyr motif.

Authors:  S C Li; Z Songyang; S J Vincent; C Zwahlen; S Wiley; L Cantley; L E Kay; J Forman-Kay; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization.

Authors:  Ivan M Blasutig; Laura A New; Ajitha Thanabalasuriar; Thamara K Dayarathna; Marilyn Goudreault; Susan E Quaggin; Shawn S-C Li; Samantha Gruenheid; Nina Jones; Tony Pawson
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

Review 6.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

7.  Role of the Caenorhabditis elegans Shc adaptor protein in the c-Jun N-terminal kinase signaling pathway.

Authors:  Tomoaki Mizuno; Kota Fujiki; Aya Sasakawa; Naoki Hisamoto; Kunihiro Matsumoto
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

8.  Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif.

Authors:  S Tridandapani; T Kelley; M Pradhan; D Cooney; L B Justement; K M Coggeshall
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

9.  SchA-p85-FAK complex dictates isoform-specific activation of Akt2 and subsequent PCBP1-mediated post-transcriptional regulation of TGFβ-mediated epithelial to mesenchymal transition in human lung cancer cell line A549.

Authors:  Xinying Xue; Xin Wang; Yuxia Liu; Guigen Teng; Yong Wang; Xuefeng Zang; Kaifei Wang; Jinghui Zhang; Yali Xu; Jianxin Wang; Lei Pan
Journal:  Tumour Biol       Date:  2014-05-13

10.  Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1.

Authors:  Miklos Guttman; Gina N Betts; Helen Barnes; Majid Ghassemian; Peter van der Geer; Elizabeth A Komives
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.